You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

GLYBURIDE AND METFORMIN HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Glyburide And Metformin Hydrochloride, and when can generic versions of Glyburide And Metformin Hydrochloride launch?

Glyburide And Metformin Hydrochloride is a drug marketed by Actavis Elizabeth, Aurobindo Pharma, Heritage, Impax Labs Inc, Teva, and Zydus Pharms. and is included in seven NDAs.

The generic ingredient in GLYBURIDE AND METFORMIN HYDROCHLORIDE is glyburide; metformin hydrochloride. There are twenty drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the glyburide; metformin hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Glyburide And Metformin Hydrochloride

A generic version of GLYBURIDE AND METFORMIN HYDROCHLORIDE was approved as glyburide; metformin hydrochloride by IMPAX LABS INC on February 18th, 2004.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for GLYBURIDE AND METFORMIN HYDROCHLORIDE?
  • What are the global sales for GLYBURIDE AND METFORMIN HYDROCHLORIDE?
  • What is Average Wholesale Price for GLYBURIDE AND METFORMIN HYDROCHLORIDE?
Summary for GLYBURIDE AND METFORMIN HYDROCHLORIDE
Drug patent expirations by year for GLYBURIDE AND METFORMIN HYDROCHLORIDE
Recent Clinical Trials for GLYBURIDE AND METFORMIN HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
The University of Texas Health Science Center, HoustonPhase 4
Texas Tech University Health Sciences CenterPhase 3
University of Illinois at ChicagoPhase 3

See all GLYBURIDE AND METFORMIN HYDROCHLORIDE clinical trials

Pharmacology for GLYBURIDE AND METFORMIN HYDROCHLORIDE

US Patents and Regulatory Information for GLYBURIDE AND METFORMIN HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth GLYBURIDE AND METFORMIN HYDROCHLORIDE glyburide; metformin hydrochloride TABLET;ORAL 076716-001 Jun 28, 2005 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva GLYBURIDE AND METFORMIN HYDROCHLORIDE glyburide; metformin hydrochloride TABLET;ORAL 076821-003 Jan 27, 2005 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Heritage GLYBURIDE AND METFORMIN HYDROCHLORIDE glyburide; metformin hydrochloride TABLET;ORAL 079009-001 Jun 3, 2009 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Aurobindo Pharma GLYBURIDE AND METFORMIN HYDROCHLORIDE glyburide; metformin hydrochloride TABLET;ORAL 077870-001 Nov 14, 2007 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Impax Labs Inc GLYBURIDE AND METFORMIN HYDROCHLORIDE glyburide; metformin hydrochloride TABLET;ORAL 076345-002 Feb 18, 2004 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Zydus Pharms GLYBURIDE AND METFORMIN HYDROCHLORIDE glyburide; metformin hydrochloride TABLET;ORAL 206748-002 Feb 29, 2016 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Heritage GLYBURIDE AND METFORMIN HYDROCHLORIDE glyburide; metformin hydrochloride TABLET;ORAL 079009-002 Jun 3, 2009 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.